by Laura Smith | Aug 3, 2022 | Communications
Discussion around the use of a cannabis based compound to help treat insomnia symptoms Please join us for a conversation about a study published in 2021 in the journal Sleep entitled: “Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial...by Laura Smith | Aug 3, 2022 | Communications
Discussion around the use of repetitive transcranial magnetic stimulation on cannabis use disorder individuals with schizophrenia Please join us for a conversation about a study published in 2022 in the journal Schizophrenia entitled: “Investigating repetitive...by Laura Smith | Aug 3, 2022 | Communications, Weekly Cannabis News
July 22nd – July 29th, 2022 Effects of Cannabinol (CBN)-Based Solution in Mice Study results indicate that the water-soluble cannabinol compound, CBNight™ does not cause significant toxicity. Discovered nearly a century ago, cannabinol, otherwise known as CBN, is a...by Laura Smith | Aug 3, 2022 | Communications
Discussion around CBD and exercise Please join us for a conversation about a study published in 2020 in the International Journal of Physical Education, Sports, and Health entitled: “The influence of cannabidiol on delayed onset of muscle soreness”, in which Dr....by Laura Smith | Jul 28, 2022 | Communications, Weekly Cannabis News
July 1st – July 8th, 2022 The Use of Medical Cannabis as an Alternative Agent for Opioids in Managing Musculoskeletal Pain A new study found that patients suffering from musculoskeletal pain conditions reported notable reductions in pain after using medical cannabis...by Laura Smith | Jul 26, 2022 | Communications, Weekly Cannabis News
July 15th-July 22nd, 2022 Do Flavonoids Have a Future Role in the Treatment of Bladder Cancer? The flavonoid cannflavin A in combination with phytocannabinoids may be a better treatment strategy compared to chemotherapeutic agents, a new study suggests. Bladder cancer...